This trial is testing a program of remotely monitoring patients with cancer who are receiving chemo, radiotherapy, or chemoradiotherapy, and providing them with home-based care.
1 Primary · 10 Secondary · Reporting Duration: baseline to 6 months
Active Control
Experimental Treatment
300 Total Participants · 2 Treatment Groups
Primary Treatment: Supportive Oncology Care at Home · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: